FGF4 and gastrointestinal stromal tumor: Up to now, only private or hardly recurrent alterations have been identified in this GIST subgroup, such as ETV6-NTRK3, FGFR1, or FGF4 alterations, MAX, MEN1 (14–17), and still no conclusive result has been found on the actionable mutations for this subset of patients.